Litigation against telehealth companies will make medications less available.

  • 📰 PsychToday
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

ADHD medication is already in short supply. Legal action by the DOJ against illegitimate telehealth companies who prescribed unecessary medication will make the situation worse.

has been in short supply since at least October 2022. ADHD is one of the most common neurodevelopmental disorders ofthat often persists into adulthood. The estimated prevalence of adult ADHD in the United States is at least 3.5 percent. A common misconception is that stimulants are only used by college students who want to study more effectively. This is not true in most cases.

One of the primary arenas in which adults and teens with ADHD face challenges is driving. Adults with ADHD tend to be at greater risk of having accidents, receiving traffic tickets, and driving without a license. In 2021, over 3,500 people died in distraction-affected crashes caused by texting or answering a phone call while driving.

The arrest of the founder and CEO, as well as the company’s clinical president , is based on the assertion they generated more than 100 million dollars in revenue by writing prescriptions for more than 40 million pills to individuals who were targeted as “drug seekers.”company exploited the COVID pandemic to carry out a scheme to defraud taxpayers and provide easy access to Adderall and other stimulants for no legitimate purpose.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 714. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し